SCHEMBL8698385

SCHEMBL8698385

NC(=O)c1c[nH]c(C(=O)O)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.39
TSHR P16473 4/20 0.38
ADORA3 P0DMS8 1/20 0.38
MC4R P32245 1/20 0.38
ADRA1A P35348 1/20 0.38
MC3R P41968 1/20 0.38
SIRT6 Q8N6T7 2/20 0.36
ALDH1A1 P00352 1/20 0.34
ALOX15 P16050 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
KDM4E B2RXH2 1/20 0.33
ACMSD Q8TDX5 1/20 0.33
GDA Q9Y2T3 1/20 0.32
HIF1A Q16665 1/20 0.32
CGAS Q8N884 1/20 0.32
PIM1 P11309 1/20 0.32
CCNC P24863 1/20 0.31
CDK8 P49336 1/20 0.31
NNMT P40261 1/20 0.31
NOTUM Q6P988 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3821371 0.86 LMNA (0.41) LMNATSHRADORA3MC4RADRA1A
SCHEMBL87944 0.86 ALOX15 (0.41) LMNATSHRALDH1A1ALOX15TDP1
SCHEMBL4030743 0.85 LMNA (0.38) LMNATSHRADORA3MC4RADRA1A
SCHEMBL28658514 0.84 ALOX15 (0.34) LMNATSHRALOX15TDP1KDM4E
SCHEMBL27363729 0.81 LMNA (0.32) LMNATSHRALDH1A1ALOX15TDP1
SCHEMBL9387500 0.78 TDP1 (0.33) LMNATSHRALDH1A1ALOX15TDP1
SCHEMBL11168226 0.77 SIRT6 (0.42) LMNATSHRADORA3MC4RADRA1A
Pyrrole SCHEMBL5232814 0.76 LMNA (0.34) LMNAALDH1A1PIM1
SCHEMBL780237 0.76
SCHEMBL27627380 0.75 LMNA (0.36) LMNATSHRADORA3MC4RADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1998046573-A1 2-SUBSTITUTED CARBAMOYLIMIDAZOLECARBOXYLIC ACID DERIVATIVES AND VASCULAR-WALL THICKENING INHIBITOR KISSEI PHARMACEUTICAL CO., LTD. (JP) 1998-10-22 WO disclosed